PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Surgery, Austin Health, Heidelberg, Victoria, Australia marlonlperera@gmail.com.\', \'Department of Surgery, Austin Health, Heidelberg, Victoria, Australia.\', \'Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia.\', \'Respiratory and Sleep Medicine, Austin Health, Heidelberg, Victoria, Australia.\', \'Intensive Care Unit Austin Hospital, Austin Health, Heidelberg, Victoria, Australia.\', \'Department of Medicine, Austin Health, Heidelberg, Victoria, Australia.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1136/bmjopen-2020-040580
?:doi
?:hasPublicationType
?:journal
  • BMJ open
is ?:pmid of
?:pmid
?:pmid
  • 33268419
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.372
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • Randomised controlled trial for high-dose intravenous zinc as adjunctive therapy in SARS-CoV-2 (COVID-19) positive critically ill patients: trial protocol.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33268419>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33268419>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all